The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
The UK Standardisation of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial
Open accessAbstract
Summary Background The international standard radiotherapy schedule for early breast cancer delivers 50 Gy in 25 fractions of 2·0 Gy over 5 weeks, but there is a long history of non-standard regimens delivering a lower total dose using fewer, larger fractions (hypofractionation). We aimed to test the benefits of radiotherapy schedules using fraction sizes larger than 2·0 Gy in terms of local-regional tumour control, normal tissue responses, quality of life, and economic consequences in women prescribed post-operative radiotherapy. Methods Between 1999 and 2001, 2215 women with early breast cancer (pT1-3a pN0-1 M0) at 23 centres in the UK were randomly assigned after primary surgery to receive 50 Gy in 25 fractions of 2·0 Gy over 5 weeks or 40 Gy in 15 fractions of 2·67 Gy over 3 weeks. Women were eligible for the trial if they were aged over 18 years, did not have an immediate reconstruction, and were available for follow-up. Randomisation method was computer generated and was not blinded. The protocol-specified principal endpoints were local-regional tumour relapse, defined as reappearance of cancer at irradiated sites, late normal tissue effects, and quality of life. Analysis was by intention to treat. This study is registered as an International Standard Randomised Controlled Trial, number ISRCTN59368779. Findings 1105 women were assigned to the 50 Gy group and 1110 to the 40 Gy group. After a median follow up of 6·0 years (IQR 5·0–6·2) the rate of local-regional tumour relapse at 5 years was 2·2% (95% CI 1·3–3·1) in the 40 Gy group and 3·3% (95% CI 2·2 to 4·5) in the 50 Gy group, representing an absolute difference of −0·7% (95% CI −1·7% to 0·9%)—ie, the absolute difference in local-regional relapse could be up to 1·7% better and at most 1% worse after 40 Gy than after 50 Gy. Photographic and patient self-assessments indicated lower rates of late adverse effects after 40 Gy than after 50 Gy. Interpretation A radiation schedule delivering 40 Gy in 15 fractions seems to offer rates of local-regional tumour relapse and late adverse effects at least as favourable as the standard schedule of 50 Gy in 25 fractions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Hospital Anxiety and Depression Scale
Zigmond, A. S., & Snaith, R. P. (1983) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1983.tb09716.x · Cited by 47,139
Aaronson, N. K., Ahmedzai, S., Bergman, B., Bullinger, M., Cull, A., Duez, N. J., Filiberti, A., Flechtner, H., Fleishman, S. B., Haes, J. C. J. M. D., et al. (1993) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/85.5.365 · Cited by 16,005
Fisher, B., Redmond, C., Fisher, E. R., Bauer, M., Wolmark, N., Wickerham, D. L., Deutsch, M., Montague, E., Margolese, R., & Foster, R. (1985) · New England Journal of Medicine · doi:10.1056/nejm198503143121102 · Cited by 1,376
Sprangers, M. A., Groenvold, M., Arraras, J. I., Franklin, J., te Velde, A., Muller, M., Franzini, L., Williams, A., de Haes, H. C., Hopwood, P., et al. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.10.2756 · Cited by 1,220
(2008) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70077-9 · Cited by 1,132
A body image scale for use with cancer patients
Hopwood, P., Fletcher, I., Lee, A., & Al Ghazal, S. (2001) · European Journal of Cancer · doi:10.1016/s0959-8049(00)00353-1 · Cited by 984
Fisher, B., Costantino, J., Redmond, C., Fisher, E., Margolese, R., Dimitrov, N., Wolmark, N., Wickerham, D. L., Deutsch, M., Ore, L., et al. (1993) · New England Journal of Medicine · doi:10.1056/nejm199306033282201 · Cited by 827
Radiotherapy after Breast-Preserving Surgery in Women with Localized Cancer of the Breast
Veronesi, U., Luini, A., Del Vecchio, M., Greco, M., Galimberti, V., Merson, M., Rilke, F., Sacchini, V., Saccozzi, R., Savio, T., et al. (1993) · New England Journal of Medicine · doi:10.1056/nejm199306033282202 · Cited by 751
Calculating the number needed to treat for trials where the outcome is time to an event
Altman, D. G., & Andersen, P. K. (1999) · BMJ · doi:10.1136/bmj.319.7223.1492 · Cited by 710
Fyles, A. W., McCready, D. R., Manchul, L. A., Trudeau, M. E., Merante, P., Pintilie, M., Weir, L. M., & Olivotto, I. A. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040595 · Cited by 651
Owen, J. R., Ashton, A., Bliss, J. M., Homewood, J., Harper, C., Hanson, J., Haviland, J., Bentzen, S. M., & Yarnold, J. R. (2006) · The Lancet Oncology · doi:10.1016/s1470-2045(06)70699-4 · Cited by 609
Clark, R. M., Whelan, T., Levine, M., Roberts, R., Willan, A., McCulloch, P., Lipa, M., Wilkinson, R. H., & Mahoney, L. J. (1996) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/88.22.1659 · Cited by 586
Yarnold, J., Ashton, A., Bliss, J., Homewood, J., Harper, C., Hanson, J., Haviland, J., Bentzen, S., & Owen, R. (2005) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2005.01.005 · Cited by 506
van Dongen, J. A., Bartelink, H. G. M. M., Is, F., Lerut, A., Mignolet, F., Olthuis, G., van der Schueren, E., Sylvester, R. J., de Winter, J. G., & van Zijl, K. (1992) · PubMed · Cited by 440
Hopwood, P., Haviland, J., Mills, J., Sumo, G., & M Bliss, J. (2007) · The Breast · doi:10.1016/j.breast.2006.11.003 · Cited by 211
Late cosmetic results of short fractionation for breast conservation
Olivotto, I. A., Weir, L. M., Kim‐Sing, C., Bajdik, C. D., Trevisan, C. H., Doll, C. M., Lam, W.-Y., Basco, V. E., & Jackson, S. M. (1996) · Radiotherapy and Oncology · doi:10.1016/s0167-8140(96)91824-1 · Cited by 134
A shorter fractionation schedule for postlumpectomy breast cancer patients
Shelley, W. E., Brundage, M., Hayter, C. R. R., Paszat, L. F., Zhou, S., & Mackillop, W. J. (2000) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(00)00567-8 · Cited by 98
Yamada, Y. J., Ackerman, I., Franssen, E., MacKenzie, R. G., & Thomas, G. (1999) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(98)00507-0 · Cited by 66
Peters, M. V. (1967) · JAMA · doi:10.1001/jama.200.2.134 · Cited by 46
Cited by
Nishimura, R., Osako, T., Nishiyama, Y., Tashima, R., Nakano, M., Fujisue, M., Toyozumi, Y., & Arima, N. (2013) · Oncology · doi:10.1159/000353099 · Cited by 13,166
Goldhirsch, A., Wood, W. C., Coates, A. S., Gelber, R. D., Thürlimann, B., & Senn, H.-J. (2011) · Annals of Oncology · doi:10.1093/annonc/mdr304 · Cited by 3,836
Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Aebi, S., Davidson, T., Gruber, G., & Castiglione, M. (2010) · Annals of Oncology · doi:10.1093/annonc/mdq159 · Cited by 2,842
Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Cardoso, F., Kyriakides, S., Ohno, S., Penault-Llorca, F., Poortmans, P., Rubio, I. T., Zackrisson, S., & Senkus, E. (2019) · Annals of Oncology · doi:10.1093/annonc/mdz173 · Cited by 2,214
Long-Term Results of Hypofractionated Radiation Therapy for Breast Cancer
Whelan, T. J., Pignol, J.-P., Levine, M. N., Julian, J. A., MacKenzie, R., Parpia, S., Shelley, W., Grimard, L., Bowen, J., Lukka, H., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0906260 · Cited by 1,878
Metadata
- Venue
- The Lancet
- Publisher
- Elsevier BV
- Published
- 2008-03
- Volume
- 371
- Issue
- 9618
- Pages
- 1098-1107
- ISSN
- 0099-5355 (ISSN-L)
- 0140-6736
- OpenAlex
- W1830334259
- Cited by
- 1,417
- References
- 20
- FWCI
- 25.07
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.